series-b
Stage
1
Investors
About
Altesa BioSciences is a clinical-stage pharmaceutical company developing vapendavir, an oral antiviral medicine targeting rhinovirus to prevent acute exacerbations in chronic lung diseases such as COPD and asthma.
Explore Altesa BioSciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.